All FDA-approved EMA-approved PMDA-approved
Target Card Uniprot Example: P23975

povidone-iodine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definition	Drug id	CAS RN
radiopharmaceuticals, iodine-contained	4249	25655-41-8

Description:

Molecule	Description
Synonyms: povidone-iodine povidone iodine iodine-povidone complex iodovidone proviodine	An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes. Molecular weight: Formula: I2(C6H9NO)n CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Drug dosage:

Dose	Unit	Route
0.20	g	V

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

Date	Agency	Company	Orphan
Nov. 29, 1985	FDA	BECTON DICKINSON

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Toxic anterior segment syndrome	812.93	17.70	157	13069	2093	90613128
Endophthalmitis	698.14	17.70	157	13069	4528	90610693
Hypopyon	234.73	17.70	48	13178	866	90614355
Corneal oedema	174.21	17.70	43	13183	1858	90613363
Visual acuity reduced	157.19	17.70	74	13152	23336	90591885
Drug hypersensitivity	128.86	17.70	237	12989	463372	90151849
Anterior chamber cell	127.91	17.70	28	13198	708	90614513
Vitritis	115.68	17.70	30	13196	1584	90613637
Tonsillar ulcer	113.61	17.70	22	13204	296	90614925
Aqueous fibrin	106.42	17.70	18	13208	105	90615116
Retinopathy of prematurity	104.08	17.70	21	13205	353	90614868
Eye pain	103.55	17.70	70	13156	44098	90571123
Onychomadesis	96.31	17.70	68	13158	45930	90569291
Anterior chamber fibrin	91.11	17.70	16	13210	120	90615101
Lower respiratory tract infection viral	89.13	17.70	22	13204	950	90614271
Onychomycosis	84.67	17.70	58	13168	37318	90577903
Nail bed inflammation	84.63	17.70	24	13202	1777	90613444
Bacterial endophthalmitis	84.09	17.70	16	13210	195	90615026
Streptococcal sepsis	84	17.70	28	13198	3556	90611665
Nasal mucosal disorder	79.44	17.70	23	13203	1834	90613387
Eye inflammation	79.08	17.70	33	13193	7818	90607403
Pseudomonal sepsis	78.99	17.70	28	13198	4274	90610947
C-reactive protein increased	76.30	17.70	112	13114	181277	90433944
Intraocular pressure increased	72.07	17.70	30	13196	7063	90608158
Lip ulceration	71.22	17.70	22	13204	2190	90613031
Corneal epithelium defect	65.24	17.70	15	13211	476	90614745
Conjunctival oedema	64.57	17.70	17	13209	952	90614269
Oliguria	60.46	17.70	30	13196	10594	90604627
Punctate keratitis	58.04	17.70	15	13211	781	90614440
Metastases to lymph nodes	57.75	17.70	30	13196	11659	90603562
Hepatic enzyme	55.63	17.70	23	13203	5321	90609900
Post procedural discomfort	54.67	17.70	16	13210	1325	90613896
Vascular device infection	54.29	17.70	29	13197	11923	90603298
Macular oedema	54.07	17.70	22	13204	4887	90610334
Paronychia	52.77	17.70	25	13201	7981	90607240
Parophthalmia	51.31	17.70	12	13214	411	90614810
Vitreous floaters	51.07	17.70	24	13202	7525	90607696
Ocular hyperaemia	50.81	17.70	41	13185	33757	90581464
Tonsillitis	49.76	17.70	23	13203	6946	90608275
Varicose vein	48.66	17.70	23	13203	7304	90607917
Injection site reaction	46.33	17.70	62	13164	92018	90523203
Type 2 diabetes mellitus	45.41	17.70	95	13131	203149	90412072
Metamorphopsia	44.84	17.70	14	13212	1443	90613778
Cataract nuclear	44.36	17.70	13	13213	1081	90614140
Brain oedema	41.80	17.70	28	13198	17357	90597864
Retinal haemorrhage	41.08	17.70	19	13207	5745	90609476
Candida infection	40.29	17.70	36	13190	34021	90581200
Psoriatic arthropathy	39.05	17.70	96	13130	228239	90386982
Corneal abrasion	37.82	17.70	12	13214	1304	90613917
Product use in unapproved indication	37.48	17.70	121	13105	336115	90279106
Suspected transmission of an infectious agent via product	36.29	17.70	9	13217	396	90614825
Foetal non-stress test abnormal	35.62	17.70	6	13220	34	90615187
Product contamination microbial	34.09	17.70	8	13218	278	90614943
Vision blurred	33.81	17.70	59	13167	110234	90504987
Blepharospasm	33.67	17.70	41	13185	55404	90559817
Corneal infiltrates	32.48	17.70	7	13219	164	90615057
Metastases to central nervous system	32.29	17.70	24	13202	17518	90597703
Epilepsy	32	17.70	49	13177	82157	90533064
Restlessness	31.31	17.70	32	13194	35688	90579533
Procedural pain	31.28	17.70	31	13195	33329	90581892
Off label use	31.15	17.70	270	12956	1101982	89513239
Vitreous detachment	30.87	17.70	12	13214	2366	90612855
Polyglandular disorder	30.30	17.70	7	13219	227	90614994
Rheumatic fever	30.10	17.70	68	13158	153053	90462168
Pericarditis	28.98	17.70	96	13130	270055	90345166
Ophthalmological examination abnormal	28.75	17.70	6	13220	120	90615101
Cystoid macular oedema	28.70	17.70	11	13215	2089	90613132
Non-infectious endophthalmitis	28.43	17.70	7	13219	299	90614922
Underdose	28.13	17.70	37	13189	53980	90561241
C-reactive protein abnormal	27.78	17.70	59	13167	127370	90487851
Anterior chamber disorder	27.59	17.70	6	13220	147	90615074
Blindness unilateral	27.56	17.70	16	13210	7720	90607501
Retinal scar	27.28	17.70	6	13220	155	90615066
Eczema	27.20	17.70	36	13190	52834	90562387
Cataract operation complication	26.92	17.70	6	13220	165	90615056
Toxicity to various agents	26.42	17.70	5	13221	287841	90327380
Vitreous haemorrhage	26.32	17.70	11	13215	2615	90612606
Visual impairment	26.25	17.70	59	13167	132306	90482915
Retinal disorder	26.04	17.70	10	13216	1909	90613312
Eye oedema	25.87	17.70	10	13216	1942	90613279
Sleep disorder	25.50	17.70	75	13151	197955	90417266
Conjunctivitis	25.38	17.70	25	13201	26681	90588540
Drug interaction	24.95	17.70	5	13221	276448	90338773
Anaemia folate deficiency	24.41	17.70	7	13219	539	90614682
Retinal pigment epithelial tear	24.17	17.70	6	13220	265	90614956
Retinal oedema	23.61	17.70	8	13218	1068	90614153
Exophthalmos	23.06	17.70	9	13217	1793	90613428
Taste disorder	22.99	17.70	36	13190	61510	90553711
Multiple use of single-use product	22.96	17.70	9	13217	1814	90613407
Transmission of an infectious agent via product	22.31	17.70	5	13221	141	90615080
Delayed delivery	22.03	17.70	4	13222	37	90615184
Blepharitis	21.95	17.70	11	13215	3965	90611256
Eyelid oedema	21.72	17.70	16	13210	11518	90603703
Product dose omission issue	21.24	17.70	8	13218	291679	90323542
Conjunctival hyperaemia	21.20	17.70	10	13216	3159	90612062
Dermatitis exfoliative generalised	21.08	17.70	12	13214	5581	90609640
Corneal opacity	20.88	17.70	7	13219	904	90614317
Genital haemorrhage	20.88	17.70	14	13212	8688	90606533
Foreign body sensation in eyes	20.82	17.70	10	13216	3290	90611931
Anaphylactic reaction	20.80	17.70	42	13184	87482	90527739
Enterocutaneous fistula	20.64	17.70	8	13218	1566	90613655
Intentional product use issue	20.57	17.70	74	13152	216818	90398403
Endocrine disorder	20.52	17.70	7	13219	953	90614268
Eye irritation	20.42	17.70	25	13201	33953	90581268
Post procedural complication	20.31	17.70	19	13207	19023	90596198
Hypoparathyroidism	20.23	17.70	7	13219	994	90614227
Iridocyclitis	19.83	17.70	10	13216	3651	90611570
Ocular toxicity	19.73	17.70	7	13219	1070	90614151
Wound	19.71	17.70	92	13134	302888	90312333
Photopsia	19.53	17.70	11	13215	5013	90610208
Chronic hepatitis	19.31	17.70	7	13219	1138	90614083
Therapeutic product effect incomplete	19.10	17.70	67	13159	193829	90421392
Retinal cyst	18.43	17.70	4	13222	97	90615124
Chest pain	18.40	17.70	12	13214	319633	90295588
Procedural haemorrhage	18.30	17.70	9	13217	3115	90612106
Breast cancer stage III	18.28	17.70	39	13187	84408	90530813
Lacrimation increased	18.05	17.70	21	13205	27041	90588180

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Endophthalmitis	531.72	25.14	113	3571	4320	42613331
Toxic anterior segment syndrome	472.28	25.14	85	3599	1331	42616320
Hypopyon	151.52	25.14	28	3656	507	42617144
Visual acuity reduced	148.01	25.14	56	3628	17494	42600157
Corneal oedema	138.07	25.14	31	3653	1517	42616134
Retinopathy of prematurity	128.97	25.14	21	3663	172	42617479
Eye pain	110.63	25.14	45	3639	16985	42600666
Vitritis	105.88	25.14	24	3660	1225	42616426
Vision blurred	98.62	25.14	60	3624	53639	42564012
Anterior chamber cell	97.98	25.14	19	3665	449	42617202
Vitreous floaters	93.94	25.14	28	3656	4202	42613449
Eye inflammation	78.90	25.14	23	3661	3195	42614456
Anterior chamber fibrin	66.18	25.14	10	3674	47	42617604
Aqueous fibrin	62.18	25.14	10	3674	75	42617576
Bacterial endophthalmitis	58.17	25.14	10	3674	117	42617534
Non-infectious endophthalmitis	56.87	25.14	11	3673	256	42617395
Ocular hyperaemia	54.77	25.14	27	3657	15936	42601715
Anaphylactic reaction	54.42	25.14	38	3646	42705	42574946
Blindness	51.73	25.14	27	3657	17951	42599700
Visual impairment	49.52	25.14	36	3648	43077	42574574
Anaphylactic shock	42.38	25.14	26	3658	23491	42594160
Vitreous disorder	36.19	25.14	7	3677	163	42617488
Macular oedema	35.96	25.14	13	3671	3556	42614095
Eye irritation	35.44	25.14	18	3666	11300	42606351
Off label use	33.92	25.14	126	3558	638209	41979442
Pseudoendophthalmitis	33.84	25.14	6	3678	85	42617566
Anterior chamber flare	33.51	25.14	6	3678	90	42617561
Eye oedema	33.49	25.14	9	3675	928	42616723
Vitreous detachment	32.77	25.14	9	3675	1007	42616644
Metamorphopsia	31.99	25.14	8	3676	621	42617030
Retinal pigment epithelial tear	31.47	25.14	7	3677	327	42617324
Urine iodine increased	30.18	25.14	4	3680	5	42617646
Pathogen resistance	29.55	25.14	16	3668	11434	42606217
Diabetic retinal oedema	28.23	25.14	6	3678	226	42617425
Haemorrhoids thrombosed	27.19	25.14	6	3678	270	42617381
Toxic skin eruption	26.84	25.14	16	3668	13714	42603937
Retinal haemorrhage	26.68	25.14	12	3672	5758	42611893
Eye infection bacterial	26.34	25.14	5	3679	105	42617546
Conjunctival hyperaemia	26.24	25.14	10	3674	3166	42614485
Facial paresis	26.02	25.14	10	3674	3240	42614411
Macular fibrosis	25.19	25.14	6	3678	380	42617271

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Toxic anterior segment syndrome	1196.25	17.98	231	15251	3223	110570594
Endophthalmitis	1067.09	17.98	244	15238	7943	110565874
Hypopyon	334.01	17.98	69	15413	1371	110572446
Corneal oedema	284.80	17.98	70	15412	3103	110570714
Visual acuity reduced	233.63	17.98	106	15376	32067	110541750
Anterior chamber cell	217.22	17.98	47	15435	1174	110572643
Vitritis	205.43	17.98	52	15430	2601	110571216
Aqueous fibrin	149.97	17.98	26	15456	188	110573629
Anterior chamber fibrin	145.93	17.98	26	15456	224	110573593
Bacterial endophthalmitis	131.52	17.98	25	15457	317	110573500
Eye pain	119.49	17.98	79	15403	50020	110523797
Tonsillar ulcer	105.90	17.98	22	15460	449	110573368
Eye inflammation	105.82	17.98	42	15440	9129	110564688
Onychomadesis	101.67	17.98	69	15413	45594	110528223
Onychomycosis	90.03	17.98	60	15422	38471	110535346
Drug hypersensitivity	89.97	17.98	197	15285	453893	110119924
Nail bed inflammation	87.23	17.98	25	15457	2005	110571812
Nasal mucosal disorder	84.55	17.98	24	15458	1859	110571958
Non-infectious endophthalmitis	82.30	17.98	18	15464	473	110573344
Lower respiratory tract infection viral	81.44	17.98	22	15460	1419	110572398
C-reactive protein increased	77.88	17.98	122	15360	217797	110356020
Ocular hyperaemia	77.22	17.98	55	15427	39231	110534586
Punctate keratitis	75.71	17.98	20	15462	1184	110572633
Streptococcal sepsis	75.62	17.98	28	15454	5044	110568773
Intraocular pressure increased	73.16	17.98	34	15448	10842	110562975
Vitreous floaters	72.35	17.98	32	15450	9102	110564715
Lip ulceration	67.18	17.98	22	15460	2756	110571061
Corneal epithelium defect	66.29	17.98	17	15465	895	110572922
Suspected transmission of an infectious agent via product	63.57	17.98	18	15464	1382	110572435
Vision blurred	63.31	17.98	84	15398	128938	110444879
Pseudomonal sepsis	63.09	17.98	29	15453	9017	110564800
Hepatic enzyme	57.32	17.98	23	15459	5140	110568677
Anaphylactic reaction	55.43	17.98	74	15408	114226	110459591
Retinal pigment epithelial tear	54.99	17.98	13	15469	487	110573330
Metastases to lymph nodes	54.52	17.98	31	15451	15001	110558816
Varicose vein	53.95	17.98	24	15458	6916	110566901
Macular oedema	53.87	17.98	24	15458	6942	110566875
Corneal infiltrates	53.53	17.98	12	15470	354	110573463
Injection site reaction	53.23	17.98	64	15418	89006	110484811
Post procedural discomfort	52.59	17.98	15	15467	1182	110572635
Type 2 diabetes mellitus	52.21	17.98	91	15391	177141	110396676
Off label use	51.55	17.98	372	15110	1499813	109074004
Vascular device infection	49.23	17.98	30	15452	16482	110557335
Paronychia	48.87	17.98	26	15456	11055	110562762
Conjunctival oedema	48.71	17.98	15	15467	1541	110572276
Metamorphopsia	47.99	17.98	15	15467	1618	110572199
Candida infection	47.33	17.98	45	15437	47964	110525853
Tonsillitis	47.07	17.98	23	15459	8190	110565627
Psoriatic arthropathy	45.42	17.98	91	15391	196670	110377147
Drug interaction	44.79	17.98	8	15474	500175	110073642
Pseudoendophthalmitis	43.64	17.98	8	15474	82	110573735
Transmission of an infectious agent via product	42.76	17.98	9	15473	196	110573621
Procedural pain	42.22	17.98	37	15445	35528	110538289
Corneal abrasion	41.65	17.98	13	15469	1396	110572421
Rheumatic fever	41.50	17.98	67	15415	122512	110451305
Retinal haemorrhage	41.07	17.98	22	15460	9479	110564338
Oliguria	41.05	17.98	28	15454	18629	110555188
Anaphylactic shock	41.01	17.98	43	15439	51503	110522314
Visual impairment	40.86	17.98	70	15412	134358	110439459
Post procedural complication	40.52	17.98	32	15450	26626	110547191
Parophthalmia	39.00	17.98	10	15472	526	110573291
Toxicity to various agents	38.32	17.98	10	15472	480545	110093272
Ocular toxicity	38.11	17.98	12	15470	1326	110572491
Wound	37.85	17.98	94	15388	234343	110339474
Pericarditis	37.66	17.98	90	15392	219024	110354793
Blepharospasm	37.08	17.98	42	15440	54809	110519008
Anterior chamber flare	36.58	17.98	8	15474	210	110573607
Product contamination microbial	36.17	17.98	11	15471	1083	110572734
Urine iodine increased	35.91	17.98	5	15477	5	110573812
Blindness	35.69	17.98	34	15448	36325	110537492
Ocular hypertension	34.82	17.98	13	15469	2395	110571422
Corneal opacity	34.72	17.98	11	15471	1240	110572577
Eye oedema	34.04	17.98	13	15469	2549	110571268
Pemphigus	33.55	17.98	85	15397	214485	110359332
Vitreous detachment	33.54	17.98	13	15469	2652	110571165
Cataract nuclear	33.46	17.98	11	15471	1395	110572422
Anterior chamber disorder	32.77	17.98	7	15475	164	110573653
Conjunctival hyperaemia	32.43	17.98	16	15466	5815	110568002
Conjunctivitis	32.03	17.98	31	15451	33761	110540056
Vitreous disorder	31.93	17.98	8	15474	383	110573434
Metastases to central nervous system	31.73	17.98	26	15456	22791	110551026
Epilepsy	31.52	17.98	53	15429	100156	110473661
Retinal disorder	31.39	17.98	12	15470	2358	110571459
C-reactive protein abnormal	31.14	17.98	61	15421	129634	110444183
Systemic lupus erythematosus	31.04	17.98	92	15390	254246	110319571
Foreign body sensation in eyes	30.72	17.98	13	15469	3321	110570496
Iridocyclitis	30.56	17.98	15	15467	5393	110568424
Brain oedema	30.37	17.98	29	15453	31069	110542748
Multiple use of single-use product	30.28	17.98	10	15472	1286	110572531
Polyglandular disorder	30.24	17.98	7	15475	239	110573578
Vitreous haemorrhage	29.70	17.98	14	15468	4606	110569211
Cataract operation complication	29.21	17.98	7	15475	278	110573539
Taste disorder	26.71	17.98	39	15443	65348	110508469
Anterior chamber inflammation	26.51	17.98	8	15474	767	110573050
Ill-defined disorder	26.48	17.98	64	15418	156789	110417028
Ophthalmological examination abnormal	26.40	17.98	5	15477	62	110573755
Eye infection bacterial	26.35	17.98	7	15475	423	110573394
Retinal scar	25.61	17.98	7	15475	472	110573345
Vitreous opacities	25.43	17.98	8	15474	881	110572936
Product dose omission issue	25.06	17.98	7	15475	321775	110252042
Blindness unilateral	24.70	17.98	16	15466	9770	110564047
Underdose	24.65	17.98	37	15445	63517	110510300
Keratic precipitates	24.57	17.98	7	15475	549	110573268
Retinal oedema	24.32	17.98	9	15473	1618	110572199
Post procedural infection	24.10	17.98	18	15464	13791	110560026
Delayed delivery	23.86	17.98	4	15478	23	110573794
Toxic skin eruption	23.77	17.98	24	15458	27491	110546326
Genital haemorrhage	23.76	17.98	14	15468	7238	110566579
Restlessness	23.62	17.98	34	15448	56225	110517592
Haemorrhoids thrombosed	23.39	17.98	6	15476	316	110573501
Anaemia folate deficiency	22.97	17.98	7	15475	694	110573123
Cystoid macular oedema	22.79	17.98	10	15472	2790	110571027
Maculopathy	22.04	17.98	10	15472	3017	110570800
Synovitis	21.85	17.98	86	15396	274006	110299811
Eye irritation	21.57	17.98	25	15457	33427	110540390
Exophthalmos	21.40	17.98	9	15473	2264	110571553
Balanitis candida	21.26	17.98	5	15477	183	110573634
Eczema	21.11	17.98	37	15445	72256	110501561
Blepharitis	20.97	17.98	11	15471	4541	110569276
Poor quality product administered	20.77	17.98	11	15471	4630	110569187
Intentional product use issue	20.75	17.98	79	15403	247827	110325990
Sleep disorder	20.66	17.98	68	15414	198576	110375241
Somnolence	20.48	17.98	8	15474	297441	110276376
Photopsia	20.37	17.98	12	15470	6202	110567615
Retinopathy of prematurity	20.33	17.98	3	15479	6	110573811
Breast cancer stage III	19.95	17.98	38	15444	79079	110494738
Lacrimation increased	19.74	17.98	23	15459	30927	110542890
Endocrine disorder	19.73	17.98	7	15475	1117	110572700
Product quality issue	19.33	17.98	37	15445	77262	110496555
Ocular discomfort	19.23	17.98	13	15469	8520	110565297
Cardiac pacemaker removal	19.23	17.98	3	15479	10	110573807
Death	18.77	17.98	44	15438	698825	109874992
Nail disorder	18.69	17.98	31	15451	57904	110515913
Macular fibrosis	18.59	17.98	6	15476	718	110573099
Chemical burn	18.40	17.98	6	15476	742	110573075
Eyelid oedema	18.36	17.98	16	15466	15246	110558571

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	D08AG02	DERMATOLOGICALS ANTISEPTICS AND DISINFECTANTS ANTISEPTICS AND DISINFECTANTS Iodine products
ATC	D09AA09	DERMATOLOGICALS MEDICATED DRESSINGS MEDICATED DRESSINGS Medicated dressings with antiinfectives
ATC	D11AC06	DERMATOLOGICALS OTHER DERMATOLOGICAL PREPARATIONS OTHER DERMATOLOGICAL PREPARATIONS Medicated shampoos
ATC	G01AX11	GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Other antiinfectives and antiseptics
ATC	R02AA15	RESPIRATORY SYSTEM THROAT PREPARATIONS THROAT PREPARATIONS Antiseptics
ATC	S01AX18	SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Other antiinfectives
FDA CS	M0011640	Iodine
FDA EPC	N0000175486	Antiseptic
MeSH PA	D000890	Anti-Infective Agents
MeSH PA	D000891	Anti-Infective Agents, Local
CHEBI has role	CHEBI:22587	antiviral agent
CHEBI has role	CHEBI:33281	antimicrobial agent
CHEBI has role	CHEBI:33282	antibacterial agent
CHEBI has role	CHEBI:35441	antiinfective agent
CHEBI has role	CHEBI:35610	antineoplastic agent
CHEBI has role	CHEBI:50177	dermatologic drug
CHEBI has role	CHEBI:66981	ophthalmology drug
CHEBI has role	CHEBI:67079	anti-inflammatory agent
CHEBI has role	CHEBI:73336	vulnerary

Related Drugs by ATC class:

D08AG Iodine products 2 drugs

diiodohydroxypropaneiodine

D09AA Medicated dressings with antiinfectives 11 drugs

aluminium chlorohydratebenzalkoniumcetylpyridiniumchlorhexidineclioquinolframycetinfusidic acidiodoformnitrofurazonephenylmercuric nitratetriclosan

D11AC Medicated shampoos 2 drugs

cetrimidexenysalate

G01AX Other antiinfectives and antiseptics 10 drugs

ciclopiroxclodantoinfurazolidonehexetidineinosinemethylrosanilinenifurateloctenidinepolicresulenprotiofate

R02AA Antiseptics 15 drugs

ambazonebenzalkoniumbenzethoniumcetrimoniumcetylpyridiniumchlorhexidinechlorquinaldoldequaliniumdichlorobenzyl alcoholeuflavinehexamidinehexylresorcinol show all 15 →

S01AX Other antiinfectives 13 drugs

bibrocatholcethexoniumchlorhexidinedibrompropamidinehexamidinelotilanernitrofurazonepicloxydinepolihexanidepropamidineresorcinolsodium borate show all 13 →

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Bacterial septicemia	contraindication	10001005	DOID:0040085
Shock	contraindication	27942005
Decreased respiratory function	contraindication	80954004
Open wound	contraindication	125643001
Seizure disorder	contraindication	128613002
Heart block	contraindication	233916004
Disease of liver	contraindication	235856003	DOID:409
Pregnancy, function	contraindication	289908002
Denuded skin	contraindication	418242004

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
4019273	VUID
N0000147472	NUI
D00863	KEGG_DRUG
4018171	VANDF
4019273	VANDF
C0032857	UMLSCUI
CHEBI:8347	CHEBI
CHEMBL1201724	ChEMBL_ID
D011206	MESH_DESCRIPTOR_UI
DB06812	DRUGBANK_ID
85H0HZU99M	UNII
8611	RXNORM
1871	MMSL
5338	MMSL
003153	NDDF
111144003	SNOMEDCT_US
386989006	SNOMEDCT_US

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Betadine	HUMAN PRESCRIPTION DRUG LABEL	1	0065-0411	SOLUTION	5 mg	OPHTHALMIC	NDA	16 sections
First Aid Antiseptic	HUMAN OTC DRUG LABEL	1	0363-0777	SOLUTION	10 mg	TOPICAL	OTC Monograph Drug	14 sections
Apothecary PVP Topical	HUMAN OTC DRUG LABEL	1	0363-0939	SOLUTION	1 g	TOPICAL	OTC monograph not final	11 sections
Walgreens Antiseptic First aid	HUMAN OTC DRUG LABEL	1	0363-3116	SPRAY	5 mg	TOPICAL	OTC Monograph Drug	12 sections
Walgreens 10 Povidone-Iodine Solution	HUMAN OTC DRUG LABEL	1	0363-3736	LIQUID	100 mg	TOPICAL	OTC Monograph Drug	12 sections
First Aid Antiseptic	HUMAN OTC DRUG LABEL	1	0363-6280	SPRAY	5 mg	TOPICAL	OTC Monograph Drug	14 sections
Humco Povidone Iodine	HUMAN OTC DRUG LABEL	1	0395-2325	LIQUID	100 mg	TOPICAL	OTC Monograph Drug	13 sections
Povidone Iodine	HUMAN OTC DRUG LABEL	1	0395-9123	LIQUID	100 mg	TOPICAL	OTC Monograph Drug	13 sections
Povidone Iodine	HUMAN OTC DRUG LABEL	1	0395-9128	LIQUID	5 mg	TOPICAL	OTC Monograph Drug	14 sections
Povidone Iodine	HUMAN OTC DRUG LABEL	1	0395-9129	LIQUID	50 mg	TOPICAL	OTC Monograph Drug	13 sections
Povidone Iodine	HUMAN OTC DRUG LABEL	1	0395-9136	LIQUID	5 mg	TOPICAL	OTC Monograph Drug	14 sections
Henry Schein Povidone-Iodine Swabsticks	HUMAN OTC DRUG LABEL	1	0404-0119	SWAB	1 g	TOPICAL	OTC Monograph Drug	13 sections
Henry Schein Povidone-Iodine Swabsticks	HUMAN OTC DRUG LABEL	1	0404-0120	SWAB	1 g	TOPICAL	OTC Monograph Drug	13 sections
Henry Schein Povidone-Iodine Prep Pad	HUMAN OTC DRUG LABEL	1	0404-0121	SWAB	1 g	TOPICAL	OTC Monograph Drug	10 sections
povidine iodine	HUMAN OTC DRUG LABEL	1	0404-5637	SWAB	10 mL	TOPICAL	OTC monograph final	11 sections
povidine iodine	HUMAN OTC DRUG LABEL	1	0404-5638	SWAB	10 mL	TOPICAL	OTC monograph final	11 sections
povidine iodine	HUMAN OTC DRUG LABEL	1	0404-5639	SWAB	10 mL	TOPICAL	OTC monograph final	11 sections
First Aid Antiseptic	HUMAN OTC DRUG LABEL	1	0536-1271	OINTMENT	100 mg	TOPICAL	OTC Monograph Drug	13 sections
povidone iodine	HUMAN OTC DRUG LABEL	1	0904-1103	SOLUTION	100 mg	TOPICAL	OTC Monograph Drug	11 sections
POVIDONE-IODINE	HUMAN OTC DRUG LABEL	1	0924-5408	SOLUTION	10 mg	TOPICAL	OTC Monograph Drug	11 sections
First Aid Only Povidone-Iodine Prep Pad	HUMAN OTC DRUG LABEL	1	0924-8110	PATCH	10 g	TOPICAL	OTC Monograph Drug	9 sections
First Aid Only Povidone-Iodine Antiseptic	HUMAN OTC DRUG LABEL	1	0924-8113	PATCH	10 g	TOPICAL	OTC Monograph Drug	12 sections
Povidone-Iodine Swabstick	HUMAN OTC DRUG LABEL	1	10819-3800	STICK	10 mg	TOPICAL	OTC Monograph Drug	10 sections
Povidone-Iodine Swabstick	HUMAN OTC DRUG LABEL	1	10819-3800	STICK	10 mg	TOPICAL	OTC Monograph Drug	10 sections
PVP Iodine Prep PadMedium and Large	HUMAN OTC DRUG LABEL	1	10819-3883	SWAB	10 mg	TOPICAL	OTC Monograph Drug	11 sections
PVP Iodine Prep PadMedium and Large	HUMAN OTC DRUG LABEL	1	10819-3883	SWAB	10 mg	TOPICAL	OTC Monograph Drug	11 sections
PVP Iodine Prep SwabstickOnes and Threes	HUMAN OTC DRUG LABEL	1	10819-3885	STICK	10 mg	TOPICAL	OTC Monograph Drug	11 sections
PVP Iodine Prep SwabstickOnes and Threes	HUMAN OTC DRUG LABEL	1	10819-3885	STICK	10 mg	TOPICAL	OTC Monograph Drug	11 sections
Profend Nasal Decolonization	HUMAN OTC DRUG LABEL	1	10819-3888	SWAB	10 mg	TOPICAL	OTC Monograph Drug	10 sections
Profend Nasal Antiseptic Kit	HUMAN OTC DRUG LABEL	1	10819-3889	SWAB	10 mg	TOPICAL	OTC Monograph Drug	10 sections